Molecular Mechanism of Insulin Resistance and Obesity


Obesity and insulin obstruction have been perceived as driving reasons for significant medical problems. We have tried to portray the atomic system of insulin obstruction, zeroing in on the capacity of adipocyte. We have researched a job of PPARγ on the pathogenesis of Type II diabetes. Heterozygous PPARγ-inadequate mice were shielded from the advancement of insulin opposition due to adipocyte hypertrophy under a high-fat eating routine. Also, a Pro12Ala polymorphism in the human PPARγ2 quality was related with diminished danger of Type II diabetes in Japanese. Taken along with these outcomes, PPARγ is end up being a frugal quality intervening Type II diabetes. Pharmacological inhibitors of PPARγ/RXR improve high-fat eating routine actuated insulin obstruction in creature models of Type II diabetes.



 


    Related Conference of Molecular Mechanism of Insulin Resistance and Obesity

    March 13-14, 2025

    8th International Conference on Obesity and Chronic Diseases

    Prague, Czech Republic
    March 24-25, 2025

    27th Global Obesity Meeting

    London, UK
    April 17-18, 2025

    5th World Summit on Obesity and Weight Management

    Madrid, Spain
    June 02-03, 2025

    21st Euro Obesity and Endocrinology Congress

    Amsterdam, Netherlands

    Molecular Mechanism of Insulin Resistance and Obesity Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in